menu search

Zynerba Pharmaceuticals Announces Further Adjournment of Annual Meeting

Zynerba Pharmaceuticals Announces Further Adjournment of Annual Meeting
Annual Meeting Reconvened and Adjourned Without Conducting Business Meeting to Reconvene on July 27, 2023 at 9:00 am EDT DEVON, Pa., June 28, 2023 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) (the “Company”), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today announced that the adjourned 2023 Annual Meeting of […] The post Zynerba Pharmaceuticals Announces Further Adjournment of Annual Meeting appea... Read More
Posted: Jun 28 2023, 20:05
Author Name: forextv
Views: 081071

Search within

Pages Search Results: